CVSC Cardiovascular Sciences Inc (CE)

Cardiovascular Sciences, Inc. (PINK SHEETS: CVSC) proudly announces it has been accepted to exhibit its line of unique health promotion products at the 12th Annual Fifty-Plus Expo at Times Square�s Marriott Marquis in New York City (www.FiftyPlusExpo.net). The annual event will be held Sunday, November 9th, 11 AM through 5 PM. It will feature presentations from several notable leaders in the field of health promotion, including Dr. Oz Garcia, David Dworkin and keynote speaker, Marianne Williamson, radio personality and author of The Ages of Miracles: Embracing the New Midlife. As many as 12,000 attendees will have a chance to see Cardiovascular Sciences� flagship cell renewal anti-aging supplement, Rejuven8 �. They will also have the opportunity to sample the Company�s exclusive Hardy Heart NutZ �, premium granola-like mix, containing over 40 natural ingredients, including various nuts, grains, seeds and exotic fruits. All the Company�s products are displayed at the retail website, www.Rejuven8online.com. Attendees will also see the Company�s unique new hingeless pillbox, containing compartments, compact but large enough, to hold even the bulkiest of today�s nutritional supplements. About Cardiovascular Sciences: Cardiovascular Sciences, Inc. is a medical device company, whose primary focus is developing a novel technology platform, addressing problems of post-surgical adhesion. Adhesions and their complications are significant problems worldwide for a range of specialists, including general, cardiothoracic, orthopedic, plastic, ophthalmologic and otolaryngology specialists to name a few. In addition, the veterinary field has tremendous need for a product that can prevent similar problems in animals. The Company's unique materials and processes promise more cost-effective and capable means to deal with a problem, devastating to many. Sponsored research at UCF and previously elsewhere indicates the Company is on the right path and progressing. In addition to anti-adhesion technology, the Company owns technology in other areas, yielding a diversified portfolio with projects in various developmental stages. One of these is represented by the company�s antioxidant cell newel formula, Rejuven8 � and a line of complementary health related offerings. Forward-looking statements here are made pursuant to Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties. Actual results could differ from those discussed. This material is information only, not an offer or solicitation to buy or sell the securities.